| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 11/11/2004 | CA2523426A1 Aza spiro alkane derivatives as inhibitors of metalloproteases |
| 11/11/2004 | CA2523152A1 Use of irinotecan for treatment of resistant breast cancer |
| 11/11/2004 | CA2523019A1 Hydroanthracene based compounds as anticancer agents |
| 11/11/2004 | CA2522809A1 Novel aniline derivatives, their manufacture and use as pharmaceutical agents |
| 11/11/2004 | CA2522262A1 Inhibitors of akt activity |
| 11/11/2004 | CA2520839A1 Quinoxalinone-3- one derivatives as orexin receptor antagonists |
| 11/11/2004 | CA2518947A1 Antiallergic composition |
| 11/10/2004 | EP1475639A2 Tumour-specific P450 protein |
| 11/10/2004 | EP1475440A2 Growth differentiation factor-3 |
| 11/10/2004 | EP1475104A1 Stabilized proteinic preparation |
| 11/10/2004 | EP1475097A2 Dermatological compositions comprising an extract of achyrocline sp (marcela), uses and process for the preparation thereof |
| 11/10/2004 | EP1475091A1 Mycophenolate mofetil - high dose oral suspensions |
| 11/10/2004 | EP1475087A2 A method for chemoprevention of prostate cancer |
| 11/10/2004 | EP1474687A2 Marks as modifiers of the p53 pathway and methods of use |
| 11/10/2004 | EP1474528A2 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer |
| 11/10/2004 | EP1474521A2 An herpes simplex virus complex |
| 11/10/2004 | EP1474519A2 Microorganism for genetic therapeutic treatment of proliferative diseases |
| 11/10/2004 | EP1474448A1 Rrp sequences and knockout mice and uses thereof |
| 11/10/2004 | EP1474445A1 Glycoisoforms of adiponectin and uses thereof |
| 11/10/2004 | EP1474442A2 Cytotoxic t-cell epitopes from chlamydia |
| 11/10/2004 | EP1474438A2 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| 11/10/2004 | EP1474437A2 Improved method for obtaining betulinic acid |
| 11/10/2004 | EP1474434A2 The eaat2 promoter and uses thereof |
| 11/10/2004 | EP1474432A1 Immunostimulatory, covalently lipidated oligonucleotides |
| 11/10/2004 | EP1474425A1 Deazapurines and uses thereof |
| 11/10/2004 | EP1474421A1 Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity |
| 11/10/2004 | EP1474420A1 Quinazoline compounds |
| 11/10/2004 | EP1474419A1 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes |
| 11/10/2004 | EP1474414A1 Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent |
| 11/10/2004 | EP1474413A2 Novel decalactones from associated fungi of marine sponges and their synthetic derivatives as medicaments |
| 11/10/2004 | EP1474408A1 N-phenyl-2-pyrimidine-amine derivatives |
| 11/10/2004 | EP1474403A2 Urea derivatives and their use as vanilloid receptor antagonists |
| 11/10/2004 | EP1474397A1 Therapeutic acridone and acridine compounds |
| 11/10/2004 | EP1474396A2 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof |
| 11/10/2004 | EP1474395A1 Nicotinamide derivates useful as p38 inhibitors |
| 11/10/2004 | EP1474393A1 Aryl ureas as kinase inhibitors |
| 11/10/2004 | EP1474391A1 Water soluble phenylglycine derivatives |
| 11/10/2004 | EP1474380A2 4-dedimethylamino tetracycline compounds |
| 11/10/2004 | EP1474177A2 Non-invasive diagnostic imaging technology for mitochondria using radiolabeled lipophilic salts |
| 11/10/2004 | EP1474175A2 Agents that regulate apoptosis |
| 11/10/2004 | EP1474168A1 7s immunoglobulin for treatment of choroidal neovascularisation |
| 11/10/2004 | EP1474153A2 Methods for particle-assisted polynucleotide immunization using a pulsed electric field |
| 11/10/2004 | EP1474150A2 Use of 2-alkoxyphenyl-substituted imidazotriazinones |
| 11/10/2004 | EP1474148A1 Treatment of neuroblastoma |
| 11/10/2004 | EP1474147A1 Pyrimidine-based compounds useful as gsk-3 inhibitors |
| 11/10/2004 | EP1474131A1 Use of anethole dithiolethione in lung cancer chemoprevention |
| 11/10/2004 | EP1474130A2 Use of compounds and compositions derived from olives for protecting cells against dna damage |
| 11/10/2004 | EP1474129A1 Use of genistein in the manufacture of a medicament for the treatment of osteoporosis and obesity, and compositions containing genistein in combination with vitamin d and k |
| 11/10/2004 | EP1474128A2 S−DIMETHYLARSINO−THIOSUCCINIC ACID S−DIMETHYLARSINO−2−THIOBENZOIC ACID S−(DIMETHYLARSINO) GLUTATHIONE AS TREATMENTS FOR CANCER |
| 11/10/2004 | EP1474127A1 Biphenyl derivatives and their use as antiandrogenic agents |
| 11/10/2004 | EP1474121A2 Small molecule antagonists of bcl2 family proteins |
| 11/10/2004 | EP1474093A2 Granzyme b inhibitors |
| 11/10/2004 | EP1370560B1 Aminomethyl-pyrroloquinazoline compounds as thrombin receptor antagonists |
| 11/10/2004 | EP1261605B1 Benzoxazole derivatives as tnf and pde iv inhibitors |
| 11/10/2004 | EP1237562B1 Process for preparing mikania extracts containing mikanolide and dihydromikanolide and use in the treatment of proliferative disorders |
| 11/10/2004 | EP1140181B1 Combination therapy of radiation and a cox-2 inhibitor for the treatment of neoplasia |
| 11/10/2004 | EP1107750B1 Pharmaceutical composition with antitumor activity on the basis of carboplatin |
| 11/10/2004 | EP1028745A4 Interferon immunotherapy |
| 11/10/2004 | EP1017384B1 Azabenzimidazole-based compounds for modulating serine/threonine protein kinase function |
| 11/10/2004 | EP0929544B1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors |
| 11/10/2004 | EP0740581B1 Yttria particulate material |
| 11/10/2004 | CN1545521A Peptide as antagonist of VEGF receptor Flt-1 |
| 11/10/2004 | CN1545512A Rapamycin dialdehydes |
| 11/10/2004 | CN1545511A Rapamycin 29-enols |
| 11/10/2004 | CN1545508A 1,2,4-trioxolane antimalarials |
| 11/10/2004 | CN1545424A Anti-cancer medicine comprising disintegrin genes and treating methods thereof |
| 11/10/2004 | CN1545423A Pharmaceutical compositions comprising polysaccharide conjugates for inhibiting the metastsis or preventing the recurrence of maligant tumor |
| 11/10/2004 | CN1545422A Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingred |
| 11/10/2004 | CN1545419A Antineoplastic combinations |
| 11/10/2004 | CN1545415A Bone anabolic compounds and methods of use |
| 11/10/2004 | CN1545413A Stabilized formulations of 6-hydroxy-3-(4-[piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene and salts thereof |
| 11/10/2004 | CN1545411A Cyclopropyl and cyclobutyl epothilone analogs |
| 11/10/2004 | CN1544637A Method for preparing mB7.1-GPI fusion proteins and their uses |
| 11/10/2004 | CN1544478A Pearl oyster monomer polysaccharide ZBP-I and extraction method and uses in preparation of drugs for tumor |
| 11/10/2004 | CN1544473A Recombinant fusion protein of mycobacterium tuberculosis Ag85B antigen and human IL-2, and its uses |
| 11/10/2004 | CN1544465A Protein for promoting nerve differentiation and resisting cell death, and its coding gene |
| 11/10/2004 | CN1544463A Screening for liver cancer metastasis related protein molecule CK19 and its uses |
| 11/10/2004 | CN1544454A Antisense nucleic acid for multiple drug resistance gene of human epidermis tumor cell |
| 11/10/2004 | CN1544442A 3,6-double(3-methyl pyridine-2yl)-S-tetrazine and transition metal complex, and its preparation and uses |
| 11/10/2004 | CN1544437A Desugar and deaminosugar FR-008 derived polyketone antibiotics |
| 11/10/2004 | CN1544423A Anti-tumour effective constituent cherimoya essence preparation method |
| 11/10/2004 | CN1544420A Inhibition of raf kinase using substituted heterocyclic ureas |
| 11/10/2004 | CN1544399A Pinellia tuber total organic acid and extraction method, and its use in preparing drugs |
| 11/10/2004 | CN1544078A Chinese patent medicine for treating leukopenia due to tumor treating radiotherapy and chemotherapy |
| 11/10/2004 | CN1544052A Medicine capable of reducing toxic and side effects in chemotherapy of malignant tumor |
| 11/10/2004 | CN1544049A Medicinal pills for clearing liver heat, dispelling toxic materials and promoting diuresis |
| 11/10/2004 | CN1544047A Chinese traditional medicine composition for treating cancer and its preparation |
| 11/10/2004 | CN1544032A Anticancer Chinese traditional extracts and preparation process and application thereof |
| 11/10/2004 | CN1544028A Leukopenia treating Chinese traditional medicine |
| 11/10/2004 | CN1544011A Application of flatstem milkvetch seed and its extract in the preparation of anti hepatic fibrosis medicine and anticancer medicine |
| 11/10/2004 | CN1544007A Novel olive kernel leaf extracts and preparation process and medical use thereof |
| 11/10/2004 | CN1543998A Chinese traditional medicine composition for treating cancer and its preparing method |
| 11/10/2004 | CN1543989A Anticancer Nizhuan San |
| 11/10/2004 | CN1543988A Chinese traditional medicine Wudu San for treating ovary cyst |
| 11/10/2004 | CN1543972A Adriamycin ultrafine fibre preparation and method for making the same |
| 11/10/2004 | CN1543965A Cucurbitacin dripping pills and preparation technique |
| 11/10/2004 | CN1543951A Hydroxycamptothecin inhalant powder and fog preparition |
| 11/10/2004 | CN1543933A Curcumin injection and method for preparing the same |
| 11/10/2004 | CN1543929A Ultrafine fibre preparation of taxol and method and apparatus for preparing the same |
| 11/10/2004 | CN1174996C Inhibitor and stimulator of stem cell proliferation and use thereof |